GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » FCF Yield %

BioArctic AB (OSTO:BIOA B) FCF Yield % : 1.73 (As of May. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BioArctic AB's Trailing 12-Month Free Cash Flow is kr309.7 Mil, and Market Cap is kr17,929.5 Mil. Therefore, BioArctic AB's FCF Yield % for today is 1.73%.

The historical rank and industry rank for BioArctic AB's FCF Yield % or its related term are showing as below:

OSTO:BIOA B' s FCF Yield % Range Over the Past 10 Years
Min: -7.44   Med: -1.05   Max: 7.21
Current: 1.73


During the past 9 years, the highest FCF Yield % of BioArctic AB was 7.21%. The lowest was -7.44%. And the median was -1.05%.

OSTO:BIOA B's FCF Yield % is ranked better than
90.42% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs OSTO:BIOA B: 1.73

BioArctic AB's FCF Margin % for the quarter that ended in Dec. 2023 was 1,155.84%.


BioArctic AB FCF Yield % Historical Data

The historical data trend for BioArctic AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB FCF Yield % Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only 3.88 -1.25 -1.38 -0.19 1.28

BioArctic AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 5.40 -1.03 -0.85 2.16

Competitive Comparison of BioArctic AB's FCF Yield %

For the Biotechnology subindustry, BioArctic AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BioArctic AB's FCF Yield % falls into.



BioArctic AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BioArctic AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=302.251 / 23650.757
=1.28%

BioArctic AB's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=127.431 * 4 / 23650.757
=2.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioArctic AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BioArctic AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of BioArctic AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioArctic AB (OSTO:BIOA B) Business Description

Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (OSTO:BIOA B) Headlines

No Headlines